Canada pharmacy shipping change 2026: what US patients should know

What is changing?

According to the Canadian International Pharmacy Association (CIPA) and contemporaneous reporting:

• New US Customs mail-entry requirements associated with the June 24, 2026 CBP interim final rule take effect on October 22, 2026.
• CIPA’s assessment (paraphrased from its public statement): unless arrangements change, Americans should expect that virtually all routine personal prescription orders mailed from licensed Canadian and international pharmacies will be unable to reach them.
• Some CIPA-member pharmacy sites have posted urgent customer notices about the cutoff.

Sources we are relying on

1. CIPA: New US Customs entry requirements to halt Rx imports
2. Pharmasist.ca (Sep 30, 2026): U.S. postal customs change could disrupt prescription shipments from Canadian pharmacies
3. Rep. Schakowsky et al. letter (Oct 1, 2026): Congressional letter on prescription drug importation (PDF)
4. Background on FDA’s longstanding personal-importation position: FDA Personal Importation
5. Separate from personal mail orders: FDA’s Section 804 state/tribal importation pathway is for authorized programs, not individual shoppers — 21 CFR Part 251

We have not independently republished the full CBP Federal Register text on this page. Read the primary CBP/Federal Register materials before making decisions that depend on legal interpretation.

How this relates to US law on personal importation

Even before this customs change, FDA has stated that in most circumstances it is illegal for individuals to import drugs into the United States for personal use. FDA describes limited enforcement-discretion scenarios (for example, serious condition, no adequate US alternative, small personal supply), which are not based on price alone.

CIPA accreditation speaks to Canadian industry standards. It does not mean a shipment is authorized under US personal-importation rules. Our directory may list CIPA pharmacies for verification and reviews only; we do not claim those shipments are legal for US patients, and we do not place affiliate links to Canadian pharmacies.

What US patients can do instead

Talk with your US licensed prescriber and pharmacist before changing how you get medicine. Options that stay within ordinary US channels include:

1. Ask your prescriber about lower-cost US alternatives — generics, therapeutic alternatives, 90-day fills, or manufacturer patient-assistance programs when you qualify.
2. Compare prescription discount cards for cash-pay prices at US pharmacies. See our comparison page: Prescription discount cards compared.
3. Check verified US online / digital pharmacies — look for LegitScript certification and/or NABP Digital Pharmacy accreditation, plus licensure in your state. Use our verification guide.
4. Editorial (non-affiliate) cash-price options people often research include Mark Cuban Cost Plus Drugs, major retail pharmacy cash prices (for example Walmart/Costco where available), and Amazon Pharmacy. We may cover these editorially without affiliate links where no program exists.
5. US telehealth for an appropriate prescription — if you need a US clinician visit to continue therapy, compare LegitScript-aware telehealth brands. Avoid any offer that skips a real clinician evaluation or pushes controlled substances.
6. Insurance and state programs — check your plan’s preferred pharmacy, prior authorization help, and any state drug affordability or importation program (state programs are not the same as ordering personally from a Canadian website).

If a medication is critical and your Canadian supply is interrupted, contact your prescriber promptly rather than waiting until you run out.

What we will update on this page

• Whether CBP or FDA issues clarifying FAQs after October 22, 2026
• Whether CIPA or major Canadian mail-order pharmacies report resumed, blocked, or alternate shipping arrangements
• Any lawful US program developments relevant to patients (with sources)

Next planned review window: on or shortly after October 22–29, 2026 (AZ).